Canada markets closed

HAVN Life Sciences Inc. (HAVLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1200-0.0060 (-4.76%)
At close: 01:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.1260
Open0.1277
BidN/A x N/A
AskN/A x N/A
Day's Range0.1120 - 0.1277
52 Week Range0.1120 - 0.9800
Volume96,410
Avg. Volume71,428
Market Cap16.763M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2550
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    HAVN Life Announces Gary Leong's Appointment to Board of Directors

    HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind, is pleased to announce the appointment of Mr. Gary Leong to its Board of Directors. Concurrently, Mr. Leong has stepped down as HAVN Life's Chief Science Officer, shifting his focus to an advisory role within the organization.

  • Baystreet

    Stocks in play: HAVN Life Sciences

    Announced it has entered into a definitive agreement to acquire all of the outstanding securities of ...

  • CNW Group

    HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.

    Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life"), a biotechnology company developing natural health products and innovative therapies to support central nervous system health and enhance the capabilities of the mind, is pleased to announce it has entered into a definitive agreement (the "Definitive Agreement") to acquire (the "Acquisition") all of the outstanding securities of Spore Life Sciences Inc. ("Spore"), on the terms and conditions set forth in t